COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria A case report
4800
[키워드] acute lung injury
Anticoagulant
approach
attenuate
benefit
Blood
Bone marrow
C5a
cascade
Case report
Cell
characterized
clinical trial
complement
Complement inhibitor
complement system activation
Concentration
cough
COVID19
COVID19 pneumonia
Critical
Department
Dexamethasone
diagnosed
discharged
disorder
Emergency
Excessive activation
hemolytic anemia
hospital
immune
Infection
initiated
injection
life-threatening
moderate
nocturnal
outcome
paroxysmal nocturnal hemoglobinuria
Patient
patients with COVID19
prothrombotic state
required
resolved
Shortness of breath
Symptom
thrombosis
Treatment
unfractionated heparin
Urine
[DOI] 10.1097/MD.0000000000025456 PMC 바로가기 [Article Type] 4800
[DOI] 10.1097/MD.0000000000025456 PMC 바로가기 [Article Type] 4800